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Abstract
Background—In China, varicella vaccine has been available in the private sector to children 
≥12 months of age since 1998 with a single-dose indication. In December 2006, varicella became 
a notifiable disease in Beijing. We used surveillance data to describe varicella vaccine uptake from 
2005 to 2010 and varicella epidemiology in Beijing from 2007 to 2010.
Methods—Limited sociodemographic and clinical information was available from the passive 
surveillance system. Varicella vaccine coverage was estimated for each year for children born 
between 2004 and 2008 using the number of children in the immunization registry of each birth 
year as the denominator without adjustment for history of varicella.
Results—Vaccine coverage increased within each birth cohort between 2005 and 2010. The 
coverage at 2 years of age increased from 62.4% in 2005 to 74.1% in 2010 and was 80.4% in 
children 3–6 years of age in 2010. Between 2007 and 2010, 15,544 to 18,256 varicella cases were 
reported annually with stable overall incidence (range: 1.0–1.1/1000 persons), but the incidence in 
children 1–4 years of age decreased significantly from 6.2 per 1000 children in 2007 to 4.4 per 
1000 children in 2010 (P < 0.001). Among adults (≥20 years of age), there were significant 
increases in the number and proportion of cases from 2557 (16.5%) in 2007 to 4277 (23.4%) in 
2010 (P < 0.001).
Conclusions—Moderately high 1-dose vaccine coverage in young children has been achieved 
with declining disease incidence, but varicella remains a common, seasonal disease in the 
population. Current epidemiology suggests that a government-funded varicella vaccine program 
that includes catch-up vaccination for older children, adolescents and adults needs consideration.
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Varicella (chickenpox) is a highly contagious disease caused by the varicella zoster virus, 
which, in the absence of vaccination, is a universal infection acquired mainly in childhood. 
Varicella vaccines are widely available globally; in Beijing, 3 vaccines are available: 
Varilrix of GlaxoSmithKline Biologicals (Rixensart, Belgium), licensed in 1998, and 2 
vaccines manufactured in China (Changchun Keygen Biological Products Co., Ltd, Jilin, 
China and Shanghai Institute of Biological Products, Shanghai, China), which were both 
licensed in 2000. Currently, varicella vaccine is not included in the Expanded Program on 
Immunization in China, but is available for private purchase for individuals ≥12 months of 
age with a single-dose indication. In Beijing, varicella became a notifiable disease in 
December 2006. Since mid-2006, free varicella vaccine has been provided to affected 
schools in response to school outbreaks. We used data from varicella passive surveillance, 
reported outbreaks and the Beijing immunization registry to describe varicella epidemiology 
from 2007 to 2010 and varicella vaccine coverage since 2005.
METHODS
Varicella Definition and Reporting
For surveillance purposes, varicella is defined as a clinically diagnosed illness with acute 
onset of a diffuse maculopapulovesicular rash without other apparent cause. All clinical 
practitioners are required to report varicella cases electronically via the National Notifiable 
Infectious Diseases Reporting Information System within 24 hours to the local health 
department. Information collected from cases includes name, sex, date of birth, profession, 
address, date of rash onset and date of diagnosis. In Beijing, a varicella outbreak is defined 
as ≥5 cases in a school or other setting within 1 week. School outbreaks are investigated to 
collect detailed information on cases’ clinical presentations and vaccination status. Free 
varicella vaccine is provided for outbreak control to school students without a history of 
varicella or vaccination in kindergarten, elementary, middle and high schools. We used 
estimated census data as denominators to calculate the overall varicella incidence in Beijing. 
However, because of concern with age-specific population estimates derived from modeled 
census data in Beijing during the study period, we calculated annual varicella incidence in 
children aged 1–4 years between 2007 and 2010 using a denominator of children identified 
from birth registrations (Beijing residents) and children of the migrant population (<6 
months of residence in Beijing during the year who are enumerated) during yearly outreach 
immunization campaigns for vaccine-preventable diseases covered by the Expanded 
Program on Immunization.
Vaccine Delivery and Varicella Vaccine Coverage Estimation
In Beijing, administration of all private and publically funded vaccines occurs in 
approximately 600 immunization clinics. In 2008, Beijing established an electronic 
immunization registry and requested that immunization providers record every vaccine 
administered to children 0–6 years of age including privately purchased vaccines, in the 
registry. In addition, retrospective records of vaccines administered in clinics since 2004 
were entered into the registry. Varicella vaccine doses administered in schools for outbreak 
control are not recorded in the immunization registry. We used the children enrolled in the 
immunization registry in early 2011 to define birth cohorts from 2004 to 2008. We 
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calculated varicella vaccination coverage using the cumulative number of children who had 
received varicella vaccine in each birth cohort each year divided by the total number of 
children in the corresponding birth cohorts in the registry in early 2011 without excluding 
those with prior varicella disease history because this information was not available.
Statistical Analyses
We used the Kruskal–Wallis or Mantel–Haenszel χ2 tests to evaluate the distribution of 
continuous or categorical variables related to varicella disease from 2007 to 2010. 
Geographic regions within Beijing were defined as rural, suburb and urban according to the 
level of urbanization in each county. All statistical analyses were performed with SAS V9.3 
(SAS Institute, Cary, NC).
RESULTS
Epidemiology and Seasonality of the Varicella Disease
Between 2007 and 2010, 15,544 to 18,256 varicella cases were reported annually (Table 1). 
Fifty-six percent of the cases were male with a median age of 9 years (range: 0 month to 85 
years). Twenty-one percent of the cases were <5 years of age, 29.6% were 5–9 years of age, 
11.9% were 10–14 years of age and 37.2% were ≥15 years of age. The majority (68.3%) of 
the cases were students in kindergarten, elementary, middle or high schools. Adults (≥20 
years of age) comprised 19.9% of the cases, of whom 3.9% (526) were healthcare workers. 
There was little change in the overall incidence from 2007 to 2010 (range: 1.0–1.1/1000 
persons). However, the incidence in children 1–4 years of age decreased significantly from 
6.2 per 1000 children in 2007 to 4.4 per 1000 children in 2010 (P < 0.001).
From 2007 to 2010, the proportion and reported number of adults cases ≥20 years of age 
increased significantly from 16.5% (2557 cases) in 2007 to 23.4% (4277 cases) in 2010 (P < 
0.001 for trend). Little change was observed in geographic distribution of the cases from 
2007 to 2010, except some yearly fluctuation (Table 1). The proportions of cases that were 
adults was highest in urban, followed by suburban and rural areas (P < 0.001 for trend), and 
these proportions increased in all areas from 22.1%, 18.8%, 12.9% of all cases in 2007 to 
32.9%, 25.2% and 19.2% in 2010, respectively (P < 0.001).
Varicella had a seasonal pattern with 2 incidence peaks (April to June and November to 
January) and 2 troughs (February and August to September) each year (Fig. 1A). The 2-peak 
seasonality was most prominent in cases reported among students, (Fig. 1B), and least 
prominent, with only 1 major peak per year in the nonstudent cases (Fig. 1C). From 2007 to 
2010, there was no change in pattern of seasonality in any of the age groups, even in those 
1–4 years of age (Fig. 1D).
Varicella Outbreaks
A total of 303 outbreaks with 3845 cases (5.7% of total reported cases) were reported from 
2007 to 2010. There was no significant change in the number of outbreaks or outbreak-
related cases, the average size of the outbreaks or the proportion of outbreaks with <10 
cases. Approximately 67.7% of the reported outbreaks occurred in elementary schools and 
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correspondingly, more than half (61.4%–74.7%) of the outbreak cases were 5–9 years of 
age. The proportion of outbreak cases that were vaccinated was higher in kindergartens and 
elementary schools than in middle and high schools (65.8% versus 27.3%; P < 0.001); this 
proportion increased from 60.6% to 78.2% of kindergarten student cases and from 48.6% to 
77.7% of elementary school student cases (P < 0.001 for both) during 2007 to 2010 (Fig. 2). 
In contrast, in outbreaks in middle and high schools, most cases were unvaccinated or had 
unknown vaccination status; however, the proportion of vaccinated cases increased from 
23.8% in 2007 to 37.9% in 2010 (P = 0.02; Fig. 2). The proportion of outbreak cases with 
mild rash (<50 lesions) increased significantly from 65.8% in 2007 to 75.2% in 2010 in all 
outbreak cases (P < 0.001).
Single-dose Varicella Vaccination Coverage
Among children 1 year of age, vaccine coverage ranged from 27.9% in 2005 to 52.4% in 
2009. By 2010, vaccine coverage was 79.2% in children 2–6 years of age (range: 74.1% for 
children 2 years of age to 81.5% for children 5 years of age; Fig. 3). The doses of privately 
purchased vaccines ranged from 161,560 doses in 2007 to 186,695 doses in 2010; however, 
doses for outbreak control decreased by 55% from 112,639 in 2007 to 50,288. 
Consequently, the proportion of all doses that were administered for outbreak control 
decreased from 41% in 2007 to 21% in 2010.
DISCUSSION
Using data collected from passive varicella surveillance and the Beijing immunization 
registry, our study provides the first description of current varicella epidemiology and 
coverage levels for varicella vaccine in Beijing. The unique biphasic pattern of disease is 
driven by school-aged children who have 2 breaks per year: the first trough in incidence in 
February coincides with the 4-week school break for Chinese New Year—a long enough 
time period to interrupt ongoing student transmission with the second trough during the 
summer when school is in recess, as described globally.1,2
Uptake of varicella vaccine in Beijing has been fairly rapid with moderately high 1-dose 
coverage (approximately 80%) among children 3–6 years of age by 2010. Factors that may 
contribute to this high coverage include the lower price of domestic vaccines in Beijing (25 
US dollars for domestic vaccines, considerably cheaper than approximately 50 US dollars 
for Varilrix globally) and the fact that kindergartens and elementary schools recommend that 
parents consider vaccinating their children to avoid missing school and to reduce the 
likelihood of school closures during outbreaks.
In contrast to the experience in the United States where evidence of vaccine impact was 
present across the age spectrum,3 these levels of coverage among preschool children appear 
to have impacted varicella incidence among children aged 1–4 years, but have had little 
impact on overall disease incidence and on varicella seasonality as detected through this 
surveillance system. This may be due to inaccurate vaccine coverage assessment using 
registry data or less catch-up vaccination among school children who drive the disease 
seasonality. Limitations of the surveillance system with inability to track incidence in all age 
groups restricts our ability to interpret early signs of vaccine impact in other age groups and 
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changing varicella epidemiology. Although the number and proportion of varicella cases 
among adults are increasing, incidence may not be increasing. These findings among adults 
may reflect the effect of rapidly changing population dynamics in Beijing. Beijing’s 
population has increased 42% over the past decade from 14 million in 2000 to 20 million in 
2010 mainly due to migrants, predominantly young adults, from rural areas. The low income 
level of the migrants makes them less likely to get vaccinated before or after moving to 
Beijing. Supporting this explanation is the fact that the highest proportion of adult cases 
occurred in urban, followed by suburb and rural areas over this surveillance period; migrants 
are more likely to work in the urban/suburban areas. The proportion of varicella cases 
occurring in adults merits close follow-up as varicella has a higher rate of complications and 
mortality among adults. A government-funded vaccination program that includes catch-up 
vaccination for adults, as well as older children and adolescents, might be warranted.4–7 
Vaccination of healthcare workers should be considered as a priority. The increasing 
proportion of breakthrough cases in the outbreaks reported, and reported outbreaks in 
schools with high single-dose coverage,8 indicate that a 2-dose vaccine regimen may need 
consideration for outbreak control or for routine childhood vaccination in Beijing.
In addition to lack of accurate denominator information that precluded examination of trends 
in age-specific incidence, other limitations should be considered when interpreting our data. 
Passive varicella surveillance in Beijing is likely to be incomplete, although it has proven to 
be adequate for monitoring trends of varicella in developed countries.9–11 Cases were not 
laboratory con-firmed, and laboratory confirmation becomes more important in monitoring 
varicella vaccination programs as more breakthrough cases with modified clinical 
presentations occur. Vaccination status and outcomes of cases including hospitalization and 
death were not recorded on the standard case investigation form, which limited our ability to 
examine trends in severe outcomes of varicella and to describe vaccination status of cases by 
age. Finally, vaccine coverage may be overestimated because unvaccinated children may be 
underrepresented in the immunization registry, or underestimated because doses 
administered for outbreak control were not included, and children with prior varicella were 
not excluded.
In summary, moderately high single-dose varicella vaccination coverage has been achieved 
in Beijing in young children and is resulting in declining varicella incidence in this age 
group. However, varicella is still common across the age spectrum suggesting much lower 
vaccine penetration in school children and other age groups. Improved surveillance and 
disease burden data are needed to guide and monitor vaccine policy decision making in 
Beijing. However, given that a considerable proportion of varicella cases are occurring 
among older adolescents and adults with the potential for an adverse shift in varicella 
epidemiology with declining varicella incidence in young children, a government-funded 
vaccination program that includes catch-up vaccination may need consideration.
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Monthly reported varicella cases in Beijing, 2007 to 2010. A, all reported cases; B, student 
cases only; C, nonstudent cases only; D, cases aged 1–4 years.
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Changes in proportion of outbreak cases by vaccination status from 2007 to 2010 in 
different school settings.
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Varicella vaccine coverage from 2007 to 2010 in children born between 2004 and 2008.
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